RN

Richard Nanji

Executive Chairman, Chief Executive Officer, Director

Lucy Scientific Discovery

Lucy Scientific Discovery Pipeline

DrugIndicationPhase
Lucy 1.0 (Psilocybin)Mental Health Disorders (e.g., Depression, Anxiety)Pre-clinical
Lucy 2.0 (Novel Psilocybin Analog)Mental Health DisordersDiscovery
Lucy 3.0 (Novel MDMA Analog)Mental Health & Addiction DisordersDiscovery
Cannabinoid-based FormulationsChronic Pain, Neurological ConditionsPre-clinical